Mark R. Player

3.1k citations

97 papers · 2.5k indexed · h-index 28

Impact in

Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
Organic Chemistry top 2%
- Synthesis and biological activity
- Catalytic C–H Functionalization Methods
- Synthesis and Biological Evaluation
- Multicomponent Synthesis of Heterocycles
- Click Chemistry and Applications

Papers in ⓘ

Pharmaceutical Science 12
- Advancements in Transdermal Drug Delivery 11
Organic Chemistry 37
- Quinazolinone synthesis and applications 10
- Synthesis and Biological Evaluation 8
- Multicomponent Synthesis of Heterocycles 8

Co-authors: Sharmila Patel (6 shared papers)Raymond J. Patch (13 shared papers)J. Walter Sowell (16 shared papers)Bozena Michniak (11 shared papers)Paul F. Torrence (18 shared papers)Wing S. Cheung (7 shared papers)Richard S. Pottorf (11 shared papers)Naresh K. Chadha (7 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (23 papers)Journal of Medicinal Chemistry (10 papers)International Journal of Pharmaceutics (7 papers)Tetrahedron Letters (4 papers)Journal of Pharmaceutical Sciences (2 papers)
Partner nations: United States Belgium United Kingdom

In The Last Decade

Mark R. Player

97 papers receiving 2.4k citations

Peers

Countries citing papers authored by Mark R. Player

Since Specialization

Citations

This map shows the geographic impact of Mark R. Player's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Player with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Player more than expected).

Fields of papers citing papers by Mark R. Player

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Player. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Player. The network helps show where Mark R. Player may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark R. Player, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark R. Player Line = papers co-authored together Mark R. Player links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation Pharmacology & Therapeutics ·Mark R. Player, Paul F. Torrence	1998	222
2	Parallel synthesis of benzoxazoles via microwave-assisted dielectric heating Tetrahedron Letters ·Richard S. Pottorf, Naresh K. Chadha, Mārtiņš Katkevičs, Vita Ozola, Edgars Sūna, Hadi Ghane, Tor Regberg, Mark R. Player	2003	128
3	Identification of Diaryl Ether-Based Ligands for Estrogen-Related Receptor α as Potential Antidiabetic Agents Journal of Medicinal Chemistry ·Raymond J. Patch, Lily L. Searle, Alexander J. Kim, Debyendu De, Xizhen Zhu, Hossein B. Askari, John O’Neill, M.C. Abad, Dionisios Rentzeperis, Jianying Liu, Michael Kemmerer, Ling Lin, Jyotsna Kasturi, John G. Geisler, James M. Lenhard, Mark R. Player, Micheal D. Gaul	2011	110
4	A Tandem Heck-Carbocyclization/Suzuki-Coupling Approach to the Stereoselective Syntheses of Asymmetric 3,3-(Diarylmethylene)indolinones The Journal of Organic Chemistry ·Wing S. Cheung, Raymond J. Patch, Mark R. Player	2005	106
5	Colony-Stimulating Factor-1 Receptor Inhibitors for the Treatment of Cancer and Inflammatory Disease Current Topics in Medicinal Chemistry ·Sharmila Patel, Mark R. Player	2009	98
6	Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer Expert Opinion on Investigational Drugs ·Sharmila Patel, Mark R. Player	2008	82
7	Fasiglifam (TAK-875): Mechanistic Investigation and Retrospective Identification of Hazards for Drug Induced Liver Injury Toxicological Sciences ·Monicah A. Otieno, Jan Snoeys, Wing Lam, Avi Ghosh, Mark R. Player, Alessandro Pocai, Rhys Salter, Damir Simic, Hollie S. Skaggs, Bhanu Singh, Heng‐Keang Lim	2017	66
8	Design and Optimization of Benzimidazole-Containing Transient Receptor Potential Melastatin 8 (TRPM8) Antagonists Journal of Medicinal Chemistry ·Daniel J. Parks, William H. Parsons, Raymond W. Colburn, Sanath K. Meegalla, Shelley K. Ballentine, Carl R. Illig, Na Qin, Yi Liu, Tasha L. Hutchinson, Mary Lou Lubin, Dennis J. Stone, Judith F. Baker, Craig R. Schneider, Jianya Ma, Bruce P. Damiano, Christopher M. Flores, Mark R. Player	2010	59
9	Crystal Structure of the Tyrosine Kinase Domain of Colony-stimulating Factor-1 Receptor (cFMS) in Complex with Two Inhibitors Journal of Biological Chemistry ·Carsten J. Schubert, Céline Schalk‐Hihi, Geoffrey T. Struble, Hongchang Ma, Ioanna P. Petrounia, Benjamin Brandt, Ingrid C. Deckman, Raymond J. Patch, Mark R. Player, John Spurlino, Barry A. Springer	2006	56
10	Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity Bioorganic & Medicinal Chemistry Letters ·Kristi Leonard, Juan Marugán, Pierre Raboisson, Raul R. Calvo, Joan M. Gushue, Holly K. Koblish, Jennifer Lattanze, Shuyuan Zhao, Maxwell D. Cummings, Mark R. Player, Anna C. Maroney, Tianbao Lu	2006	49
11	In vitro evaluation of a series of Azone analogs as dermal penetration enhancers. II. (Thio) amides International Journal of Pharmaceutics ·Bozena Michniak, Mark R. Player, L.C. Fuhrman, Christin Christensen, James Chapman, J. Walter Sowell	1993	48
12	2-Hydroxy-4,6-diamino-[1,3,5]triazines: A Novel Class of VEGF-R2 (KDR) Tyrosine Kinase Inhibitors Journal of Medicinal Chemistry ·Nand Baindur, Naresh K. Chadha, Benjamin Brandt, Davoud Asgari, Raymond J. Patch, Céline Schalk‐Hihi, Theodore E. Carver, Ioanna P. Petrounia, Christian A. Baumann, Heidi M. Ott, Carl L. Manthey, Barry A. Springer, Mark R. Player	2004	48
13	Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Mark J. Wall, Jinsheng Chen, Sanath K. Meegalla, Shelley K. Ballentine, Kenneth J. Wilson, Renée L. DesJarlais, Carsten J. Schubert, Margery A. Chaikin, Carl Crysler, Ioanna P. Petrounia, Robert R. Donatelli, Edward J. Yurkow, Lisa Boczon, Marie J. Mazzulla, Mark R. Player, Raymond J. Patch, Carl L. Manthey, Christopher J. Molloy, Bruce E. Tomczuk, Carl R. Illig	2008	45
14	7-Fluoroindazoles as Potent and Selective Inhibitors of Factor Xa Journal of Medicinal Chemistry ·Yu‐Kai Lee, Daniel J. Parks, Tianbao Lu, Tho V. Thieu, Thomas Markotan, Wenxi Pan, David F. McComsey, Karen L. Milkiewicz, Carl Crysler, Nisha Ninan, M.C. Abad, Edward C. Giardino, Bruce E. Maryanoff, Bruce P. Damiano, Mark R. Player	2007	45
15	Potent inhibition of respiratory syncytial virus replication using a 2-5A-antisense chimera targeted to signals within the virus genomic RNA Proceedings of the National Academy of Sciences ·Mark R. Player, Dale L. Barnard, Paul F. Torrence	1998	42
16	Structure-based design, synthesis, and biological evaluation of novel 1,4-diazepines as HDM2 antagonists Bioorganic & Medicinal Chemistry Letters ·Pierre Raboisson, Juan Marugán, Carsten J. Schubert, Holly K. Koblish, Tianbao Lu, Shuyuan Zhao, Mark R. Player, Anna C. Maroney, Rolanda L. Reed, Norman Huebert, Jennifer Lattanze, Daniel J. Parks, Maxwell D. Cummings	2005	41
17	Discovery of novel FMS kinase inhibitors as anti-inflammatory agents Bioorganic & Medicinal Chemistry Letters ·Carl R. Illig, Jinsheng Chen, Mark J. Wall, Kenneth J. Wilson, Shelley K. Ballentine, Matthias Rudolph, Renée L. DesJarlais, Yanmin Chen, Carsten J. Schubert, Ioanna P. Petrounia, Carl Crysler, Christopher J. Molloy, Margery A. Chaikin, Carl L. Manthey, Mark R. Player, Bruce E. Tomczuk, Sanath K. Meegalla	2008	40
18	Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK) Bioorganic & Medicinal Chemistry Letters ·Charles L. Cywin, Baoping Zhao, Daniel W. McNeil, Matt Hrapchak, Anthony S. Prokopowicz, Daniel R. Goldberg, Tina M. Morwick, Amy Gao, Scott Jakes, Mohammed A. Kashem, Ronald L. Magolda, Richard Söll, Mark R. Player, Mark A. Bobko, James M. Rinker, Renée L. DesJarlais, Michael P. Winters	2003	40
19	Azone analogues as penetration enhancers: effect of different vehicles on hydrocortisone acetate skin permeation and retention Journal of Controlled Release ·Bozena Michniak, Mark R. Player, James Chapman, J. Walter Sowell	1994	40
20	In vitro evaluation of a series of Azone analogs as dermal penetration enhancers. I International Journal of Pharmaceutics ·Bozena Michniak, Mark R. Player, James Chapman, J. Walter Sowell	1993	38

About Mark R. Player

Mark R. Player is a scholar working on Pharmaceutical Science, Organic Chemistry, Sensory Systems, Dermatology and Toxicology, having authored 97 papers that have together received 2.5k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (19 papers), DNA and Nucleic Acid Chemistry (14 papers), Advancements in Transdermal Drug Delivery (11 papers), Quinazolinone synthesis and applications (10 papers), Contact Dermatitis and Allergies (9 papers), RNA and protein synthesis mechanisms (9 papers), Synthesis and Biological Evaluation (8 papers) and Multicomponent Synthesis of Heterocycles (8 papers). The work is most often cited by research in Pharmaceutical Science (308 citations), Organic Chemistry (924 citations), Sensory Systems (122 citations), Dermatology (151 citations) and Molecular Biology (1.0k citations). Mark R. Player has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Sharmila Patel, Raymond J. Patch, J. Walter Sowell, Bozena Michniak, Paul F. Torrence, Wing S. Cheung, Richard S. Pottorf, Naresh K. Chadha, Carsten J. Schubert and James Chapman. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, International Journal of Pharmaceutics, Tetrahedron Letters and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact